Evidence map›Paper›PMID 35373496›Full record

ArticleJournal of cachexia, sarcopenia and muscle2022

Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy.

Harmen Reyngoudt, Fiona E Smith, Ericky Caldas de Almeida Araújo, Ian Wilson, Roberto Fernández-Torrón, Meredith K James, Ursula R Moore, Jordi Díaz-Manera, Benjamin Marty, Noura Azzabou and 19 more

Registry-linked trialOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05989620 (Long-Term Development of Muscular Dystrophy Outcome Assessments), which is not on this map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05989620 recruitingnot on this mapstarted 2023, after this paper: background citation

Long-Term Development of Muscular Dystrophy Outcome Assessments (GRASP-01-005)

TypeobservationalSponsorVirginia Commonwealth UniversityRan2023 to 2029Enrolled1,000ConditionsLGMD1B, LGMD1C, LGMD1D, LGMD1E
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Progress on cell therapy for skeletal muscle disorders.Advanced drug delivery reviews · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Compositional and Functional MRI of Skeletal Muscle: A Review.Journal of magnetic resonance imaging : JMRI · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 7 institutions in 4 countries.

Harmen ReyngoudtNMR Laboratory, Neuromuscular Investigation Center, Institute of Myology, Paris, France.ORCID 0000-0002-0777-2711
Fiona E SmithMagnetic Resonance Centre, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Ericky Caldas de Almeida AraújoNMR Laboratory, Neuromuscular Investigation Center, Institute of Myology, Paris, France.
Ian WilsonMagnetic Resonance Centre, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Roberto Fernández-TorrónThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Meredith K JamesThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Ursula R MooreThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Jordi Díaz-ManeraThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Benjamin MartyNMR Laboratory, Neuromuscular Investigation Center, Institute of Myology, Paris, France.
Noura AzzabouNMR Laboratory, Neuromuscular Investigation Center, Institute of Myology, Paris, France.
Heather GordishCenter for Translational Science, Division of Biostatistics and Study Methodology, Children's National Health System, Washington, DC, USA.
Laura RufibachThe JAIN Foundation, Seattle, WA, USA.
Tim HodgsonMagnetic Resonance Centre, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Dorothy WallaceMagnetic Resonance Centre, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Louise WardMagnetic Resonance Centre, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Jean-Marc BoisserieNMR Laboratory, Neuromuscular Investigation Center, Institute of Myology, Paris, France.
Julien Le LouërNMR Laboratory, Neuromuscular Investigation Center, Institute of Myology, Paris, France.
Heather HilsdenThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Helen SutherlandThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Aurélie CanalNeuromuscular Physiology and Evaluation Laboratory, Neuromuscular Investigation Center, Institute of Myology, Paris, France.
Jean-Yves HogrelNeuromuscular Physiology and Evaluation Laboratory, Neuromuscular Investigation Center, Institute of Myology, Paris, France.
Marni JacobsCenter for Translational Science, Division of Biostatistics and Study Methodology, Children's National Health System, Washington, DC, USA.
Tanya StojkovicNeuromuscular Reference Center, Institute of Myology, Pitié-Salpêtrière Hospital (AP-HP), Paris, France.
Kate BushbyThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Anna MayhewThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Jain Clinical Outcome Study for Dysferlinopathy consortium
Volker StraubThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Pierre G CarlierUniversity Paris-Saclay, CEA, DRF, SHFJ, Orsay, France.
Andrew M BlamireMagnetic Resonance Centre, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Newcastle upon Tyne Hospitals NHS Foundation Trust · GBCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRNewcastle University · GBChildren's National · USInstitut de Myologie · FRJain Foundation · USSorbonne Université · FR

Funding

Jain Foundation
6 · The paper itself

Abstract

backgroundNatural history studies in neuromuscular disorders are vital to understand the disease evolution and to find sensitive outcome measures. We performed a longitudinal assessment of quantitative magnetic resonance imaging (MRI) and phosphorus magnetic resonance spectroscopy (

methodsQuantitative MRI/

resultsPosterior muscles in thigh and leg showed the highest FF values. FF at baseline was highly heterogeneous across patients. In ambulant patients, median annual increases in global thigh and leg segment FF values were 4.1% and 3.0%, respectively (P < 0.001). After 3 years, global thigh and leg FF increases were 9.6% and 8.4%, respectively (P < 0.001). SRM values for global thigh FF were over 0.8 for all years. Vastus lateralis muscle showed the highest SRM values across all time points. cCSA decreased significantly after 3 years with median values of 11.0% and 12.8% in global thigh and global leg, respectively (P < 0.001). Water T

conclusionsThis multi-centre study has shown that quantitative MRI/

Indexed as

Muscular Dystrophies, Limb-GirdlePhosphorusHumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMuscle, SkeletalThighWaterPhosphorusWater31P MRSDysferlinopathyLongitudinalOutcome measuresQuantitative MRI

Identifiers

PMID35373496
PMCPMC9178361
OpenAlexW4223904835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.